Home/Filings/4/0001209191-21-031110
4//SEC Filing

Viney Joanne L. 4

Accession 0001209191-21-031110

CIK 0001708493other

Filed

May 6, 8:00 PM ET

Accepted

May 7, 9:59 PM ET

Size

7.9 KB

Accession

0001209191-21-031110

Insider Transaction Report

Form 4
Period: 2021-05-04
Transactions
  • Award

    Director Stock Option (Right to Buy)

    2021-05-04+10,16710,167 total
    Exercise: $22.50Exp: 2031-05-03Common Stock (10,167 underlying)
  • Award

    Director Stock Option (Right to Buy)

    2021-05-04+2,6532,653 total
    Exercise: $22.50Exp: 2031-05-03Common Stock (2,653 underlying)
Footnotes (2)
  • [F1]The stock option will fully vest and become exercisable on May 4, 2022, subject to the continuous service of the Reporting Person with the Issuer on such date.
  • [F2]50% of the shares subject to the option are fully vested and exercisable, and 25% will vest and become exercisable on September 30, 2021 and December 31, 2021, subject to the continuous service of the Reporting Person on each vesting date.

Issuer

Harpoon Therapeutics, Inc.

CIK 0001708493

Entity typeother

Related Parties

1
  • filerCIK 0001816744

Filing Metadata

Form type
4
Filed
May 6, 8:00 PM ET
Accepted
May 7, 9:59 PM ET
Size
7.9 KB